Clinical Trials Browser

Unknown × Recurrence × daratumumab × Clear all

NCT03143036 2018-06-07

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Phase 2 Unknown

Recurrence, Neoplasms, Plasma Cell